Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06548386 · ClinicalTrials.gov registry record · NA

Feasibility and Accuracy of a Novel Pleural Drain Gas Analyzer in Detecting Air Leaks

A NA study of Pneumothorax and Air Leak From Lung, sponsored by Lung Healing Technologies.

Recruiting
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT06548386 is a NA study of Pneumothorax and Air Leak From Lung that is actively recruiting participants, run by Lung Healing Technologies. The registered enrollment target is 33 participants, below the 639-participant average among 6 other Pneumothorax trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06548386, a NA study of Pneumothorax and Air Leak From Lung, is actively recruiting participants, sponsored by Lung Healing Technologies.

RECRUITING
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to assess the clinical feasibility of a novel, reusable, low cost gas analyzer that detects breath in chest drains in order to diagnose and heal air leaks. The investigators have developed prototype gas analyzers that attach to the outlet of any analog chest drain, and can be connected temporarily to the sampling port. They detect breath by measuring CO2, O2, and pressure, in order to supplement the information provided by the bubbles in the water seal.

Interventions

  • DEVICE Pleural gas analysis

Study Locations (1)

Illinois

  • Endeavor Health - Evanston

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2025-02-05
Est. Completion 2026-06
Phase NA

Sponsor

Lung Healing Technologies

1 total trials

What the Registry Record Tells You About NCT06548386

The ClinicalTrials.gov registry entry for NCT06548386 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 639-participant average among 6 other Pneumothorax trials with a reported enrollment target (95% lower). The listed sponsor is Lung Healing Technologies, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pneumothorax appearing as the primary indexed condition, and to 1 intervention - of which Pleural gas analysis is the first listed.

NCT06548386 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06548386 about?

NCT06548386 is a clinical study titled "Feasibility and Accuracy of a Novel Pleural Drain Gas Analyzer in Detecting Air Leaks". The goal of this study is to assess the clinical feasibility of a novel, reusable, low cost gas analyzer that detects breath in chest drains in order to diagnose and heal air leaks. The investigators have developed prototype gas analyzers that attach to the outlet of any analog chest drain, and can ...

What is the current status of trial NCT06548386?

This trial is currently recruiting. It is a NA study. The enrollment target is 33 participants. The study started on 2025-02-05. Estimated completion is 2026-06.

What conditions does trial NCT06548386 study?

This clinical trial studies the following conditions: Pneumothorax, Air Leak From Lung.

What interventions are being tested in trial NCT06548386?

The interventions under investigation include: Pleural gas analysis (DEVICE).

Who is sponsoring clinical trial NCT06548386?

This trial is sponsored by Lung Healing Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06548386 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pneumothorax

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.